4.2 Article

The Marshfield Clinic Personalized Medicine Research Project: 2008 scientific update and lessons learned in the first 6 years

Journal

PERSONALIZED MEDICINE
Volume 5, Issue 5, Pages 529-542

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/17410541.5.5.529

Keywords

biobank; genetic epidemiology; methods; pharmacogenetics

Funding

  1. Department of Commerce (WI, USA) [1 D1A RH00025-01]
  2. National Center for Research Resource National Institute of Health [1 UL1RR025011]

Ask authors/readers for more resources

The Marshfield Clinic Personalized Medicine Research Project is the largest population-based biobank in the USA, with the ability to recontact subjects to obtain additional information to facilitate gene-environment studies. Nearly 20,000 adults have enrolled in the Personalized Medicine Research Project since 2001, after providing active written consent to access their Marshfield Clinic medical records to define phenotype and providing blood samples from which DNA, plasma and serum samples were stored. Numerous studies are underway in the area of pharmacogenetics and genetic epidemiology. In addition to the scientific discoveries being made, much has been learned regarding biobanking and the management of large amounts of data being generated. The purpose of this paper is to share the advice provided by the external Scientific Advisory Board and the scientific lessons learned along the way to build this research infrastructure and facilitate its use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available